1
|
Battikh R, Labbene I, Ben Abdelhafidh N,
Bahri M, Jbali A, Louzir B, M'saddek F, Ferjani M, Gargouri S,
Dhahri MA, et al: Rhinofacial mucormycosis: 3 cases. Med Mal
Infect. 33:427–430. 2003.
|
2
|
Soler ZM and Schlosser RJ: The role of
fungi in diseases of the nose and sinuses. Am J Rhinol Allergy.
26:351–358. 2012.PubMed/NCBI View Article : Google Scholar
|
3
|
Hussain S, Salahuddin N, Ahmad I,
Salahuddin I and Jooma R: Rhinocerebral invasive mycosis:
Occurrence in immunocompetent individuals. Eur J Radiol.
20:151–155. 1995.PubMed/NCBI View Article : Google Scholar
|
4
|
Bouza E, Munoz P and Guinea J:
Mucormycosis: An emerging disease? Clin Microbiol Infect. 12:7–23.
2006.
|
5
|
Brown J: Zygomycosis: An emerging fungal
infection. Am J Health Syst Pharm. 24:2593–2596. 2005.PubMed/NCBI View Article : Google Scholar
|
6
|
Rutar T and Cockerham KP: Periorbital
zygomycosis (mucormycosis) treated with posaconazole. Am J
Ophthalmol. 142:187–188. 2006.PubMed/NCBI View Article : Google Scholar
|
7
|
Notheis G, Tarani L, Costantino F, Jansson
A, Rosenecker J, Friederici D, Belohradsky BH, Reinhardt D, Seger
V, Schweinitz DV and Wintergerst U: Posaconazole for treatment of
refractory invasive fungal disease. Mycoses. 49 (Suppl 1):S37–S41.
2006.PubMed/NCBI View Article : Google Scholar
|
8
|
Singh VP, Bansal C and Kaintura M:
Sinonasal mucormycosis: A to Z. Indian J Otolaryngol Head Neck
Surg. 71 (Suppl 3):S1962–S1971. 2019.PubMed/NCBI View Article : Google Scholar
|
9
|
Greenberg RN, Mullane K, Van Burik JA,
Raad I, Abzug MJ, Anstead G, Herbrecht R, Langston A, Marr KA,
Schiller G, et al: Posaconazole as salvage therapy for zygomycosis.
Antimicrob Agents Chemother. 50:126–133. 2006.PubMed/NCBI View Article : Google Scholar
|
10
|
DeShazo RD, O'Brien M, Chapin K,
Soto-Aguilar M, Gardner L and Swain R: A new classification and
diagnostic criteria for invasive fungal sinusitis. Arch Otolaryngol
Head Neck Surg. 123:1181–1188. 1997.PubMed/NCBI View Article : Google Scholar
|
11
|
Hainarosie R, Zainea V, Rusescu A, Iana
RO, Ghindea T, Suceveanu AP, Stefanescu DC, Ionita IG, Pietrosanu C
and Stoian AP: Management of infectious complications in diabetes
mellitus mellitus patients. Romanian J Military Med. 122:46–51.
2019.
|
12
|
Ditu G, Voiculescu DC, Bodnarescu M,
Pantea Stoian A, Hainarosie R, Stefan S and Serafinceanu C:
Mucormycosis and Diabetes Mellitus. Proceedings of National ENT,
Head and Neck Surgery Conference: Arad, Romania, June 06-09, 2018,
pp. 199-204, 2018.
|
13
|
Pantea Stoian A, Hainarosie R, Stoica R,
Nitipir C, Paduraru DN, Andronache L, Oros M, Pituru S and
Serafinceanu C: MOE-A Severe Complication in Diabetes Mellitus.
Proceedings of National ENT, Head and Neck Surgery Conference,
Arad, Romania, June 6-9, 2018, pp401-405.
|
14
|
Drăgoi CM, Moroșan E, Dumitrescu IB,
Nicolae AC, Arsene AL, Drăgănescu D, Lupuliasa D, Ioniță AC, Pantea
Stoian A, Nicolae C, et al: Insight into chrononutrition: The
innermost interplay amongst nutrition, metabolism and the circadian
clock, in the context of epigenetic reprogramming. Farmacia.
67:557–571. 2019.
|
15
|
Ioacara S, Tiu C, Panea C, Nicolae H, Sava
E, Martin S and Fica S: Stroke mortality rates and trends in
Romania, 1994-2017. J Stroke Cerebrovasc Dis.
28(104431)2019.PubMed/NCBI View Article : Google Scholar
|
16
|
Țânțu MM, Stan GM, Rogozea L, Păunescu A,
Pleșa CF, Nemeș RM, Nicolae C and Bisoc A: Drug use, a valid
indicator for effective implementation of medical protocols.
Revista de Chimie. 70:859–862. 2019.
|
17
|
Chandra RK, Conley DB and Kern RC:
Evaluation of the endoscope and endoscopic sinus surgery.
Oolaryngol Clin North Am. 42:747–52. 2009.
|
18
|
Skiada A, Lanternier F, Groll AH, Pagano
L, Zimmerli S, Herbrecht R, Lortholary O and Petrikkos GL: European
Conference on Infections in Leukemia. Diagnosis and treatment of
mucormycosis in patients with hematological malignancies:
guidelines from the 3rd European Conference on Infections in
Leukemia (ECIL 3). Haematologica. 98:492–504. 2013.PubMed/NCBI View Article : Google Scholar
|
19
|
Paleiwala SK, Zangeneh TT, Goldstein SA
and Lemole GM: An aggressive multidisciplinary approach reduces
mortality in rhinocerebral. mucormycosis. 7(61)2016.PubMed/NCBI View Article : Google Scholar
|